Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein loss induced by complement activation during peritoneal dialysis.

F N Miller, D E Hammerschmidt, G L Anderson

    Kidney International
    |March 1, 1984
    PubMed
    Summary

    Complement system activation, particularly the alternative pathway, significantly increases protein loss during peritoneal dialysis. Histamine also contributes, suggesting potential therapeutic targets for managing this complication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Remarkable preference for di-substitution in self-assembled glycolipids.

    Soft matter·2025
    Same author

    Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.

    Contemporary clinical trials·2024
    Same author

    A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy.

    CPT: pharmacometrics & systems pharmacology·2016
    Same author

    Identifying and exploring factors influencing career choice, recruitment and retention of anaesthesia trainees in the UK.

    Postgraduate medical journal·2016
    Same author

    Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.

    Journal of the National Cancer Institute·2015
    Same author

    Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer.

    Climacteric : the journal of the International Menopause Society·2015

    Area of Science:

    • Nephrology
    • Immunology
    • Physiology

    Background:

    • Variable macromolecule loss occurs during peritoneal dialysis (PD) in humans and animals.
    • The role of the complement system in PD-induced protein loss is not fully understood.
    • Clinical variability in protein loss necessitates a better understanding of underlying mechanisms.

    Purpose of the Study:

    • Investigate the complement system's role in protein loss during PD.
    • Develop a model for studying complement-induced microvascular protein leakage.
    • Identify potential therapeutic targets for reducing protein loss in PD.

    Main Methods:

    • Rats received albumin-conjugated fluorescent dye and underwent simulated PD exchanges.
    • Interventions included intra-arterial or intraperitoneal injections of zymosan-activated serum, endotoxin, histamine, or vasoactive drugs.

    Related Experiment Videos

  • Dialysate protein concentration, albumin, and urea were measured via spectroscopy.

    • Main Results:

    • Zymosan-activated serum and endotoxin significantly increased dialysate protein concentrations.
    • Histamine administration also elevated protein loss.
    • Vasoactive drugs (nitroprusside, phenylephrine) did not affect protein loss.

    Conclusions:

    • Alternative pathway complement activation may explain variable protein loss in PD.
    • Histamine may mediate complement- or endotoxin-induced protein leakage.
    • Pharmacological modulation of the complement system could be a therapeutic strategy for PD.